SS
MIST icon

SBI Securities’s Milestone Pharmaceuticals MIST Stock Holding History

SBI Securities’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Sell
6
-5
-45% -$8 ﹤0.01% 3939
2026
Q1 		$13 Buy
11
+5
+83% +$9 ﹤0.01% 3818
2025
Q4 		$12 Hold
6
– – ﹤0.01% 3855
2025
Q3 		$12 Hold
6
– – ﹤0.01% 4008
2025
Q2 		$12 Buy
6
+2
+50% +$3 ﹤0.01% 3984
2025
Q1 		$3 Buy
+4
New +$8 ﹤0.01% 4067

Other funds holding MIST

PCML
Pavaki Capital Management LLC Pueblo, Colorado $287M AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
OE
October Effect Virginia Beach, Virginia $106M AUM 85.28% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities's MIST Position: Q2 2026 in Review

SBI Securities reduced its Milestone Pharmaceuticals (MIST) stake by 45% in Q2 2026, selling an estimated $8 and leaving 6 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #3939.

SBI Securities first reported a position in MIST in Q1 2025 and has held it in 6 quarters since. The position peaked at $13 in Q1 2026. 25 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • SBI Securities held 6 shares of Milestone Pharmaceuticals worth $8 as of Q2 2026.
  • SBI Securities sold 5 Milestone Pharmaceuticals shares in Q2 2026, an estimated $8.
  • Milestone Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3939 holding.
  • SBI Securities first reported a position in Milestone Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • SBI Securities's Milestone Pharmaceuticals position peaked at $13 in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.